FDA panel backs Interleukin-2

FDA Panel report: January 1998.

T he Cardiovascular and Renal Advisory Panel of the FDA met January 27-28, 1998, to discuss (1) evaluation and use of intravenous inotropic agents in patients with heart failure; (2) liver function test abnormalities with a new AT 1 receptor blocker, tasosartan; and (3) the use of the platelet IIb/IIIa receptor blocker eptifibatide in syndromes of acute cardiac ischemia. Intravenous drugs for t...

Business backs the basics.

arlier this year, a number of leaders from major U.S. corporations gathered at Sunnylands in California to discuss the critical importance of basic scientific research. For decades, the private sector has withdrawn from some areas of basic research, as accelerating market pressures, the speed of innovation, and the need to protect intellectual property in a global marketplace made a Bell Labs–s...

Boys' Backs

an unimportant amount of time bending over his desk, so that bad positions have not the opportunity of making more or less "staying" faults. But at this time a beginning may be made, either for good or bad. The boy may. be trained to sit correctly at his seat, especially when writing or drawing. lie may be trained to read with his book held before his eyes, not with the book flat upon the desk....

Backs to nature

" There's a perception that global warming is something that will happen smoothly into the future, but some of these ecosystems go into abrupt decline when warming reaches a certain threshold, " said Tim Lenton, an environmental scientist at the University of East Anglia, and lead author of the study. " If we know when the different tipping points are, we can use them to inform targets to limit...

VoiceLETS backs up first responders